Open the doors to treatments with unprecedented duration of action as well as safer and more convenient administration
The DuraLogic platform chemistry encompasses a product family integrating non-standard amino acids (NSAAs) to enhance and maintain the three-dimensional structure of proteins needed for therapeutic activity. DuraLogic NSAAs allow creation of proteins with unprecedented duration of action imparting safer and more convenient therapeutic benefits such as flatter pharmacodynamic profiles and relaxed dosing schedules.
